Cargando…
Fanconi anemia protein FANCD2 is activated by AICAR, a modulator of AMPK and cellular energy metabolism
FANCD2 is a pivotal molecule in the pathogenesis of Fanconi anemia (FA), an autosomal recessive human syndrome with diverse clinical phenotypes, including cancer predisposition, short stature, and hematological abnormalities. In our previous study, we detected the functional association of FANC prot...
Autores principales: | Chun, Min Jeong, Choi, Hana, Jun, Dong Wha, Kim, Sunshin, Kim, Yong‐Nyun, Kim, Soo‐Youl, Lee, Chang‐Hun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292659/ https://www.ncbi.nlm.nih.gov/pubmed/28174693 http://dx.doi.org/10.1002/2211-5463.12185 |
Ejemplares similares
-
Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage
por: Chun, Min Jeong, et al.
Publicado: (2016) -
Ouabain, a Cardiac Glycoside, Inhibits the Fanconi Anemia/BRCA Pathway Activated by DNA Interstrand Cross-Linking Agents
por: Wha Jun, Dong, et al.
Publicado: (2013) -
Phosphorylation of FANCD2 Inhibits the FANCD2/FANCI Complex and Suppresses the Fanconi Anemia Pathway in the Absence of DNA Damage
por: Lopez-Martinez, David, et al.
Publicado: (2019) -
Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients
por: Joksic, Ivana, et al.
Publicado: (2012) -
Defective FANCI Binding by a Fanconi Anemia-Related FANCD2 Mutant
por: Sato, Koichi, et al.
Publicado: (2014)